L
Lutz Frölich
Researcher at Heidelberg University
Publications - 296
Citations - 18355
Lutz Frölich is an academic researcher from Heidelberg University. The author has contributed to research in topics: Dementia & Alzheimer's disease. The author has an hindex of 57, co-authored 270 publications receiving 15998 citations. Previous affiliations of Lutz Frölich include Goethe University Frankfurt.
Papers
More filters
Journal ArticleDOI
Influence of SORL1 gene variants: Association with CSF amyloid-β products in probable Alzheimer's disease
Heike Kölsch,Frank Jessen,Jens Wiltfang,Piotr Lewczuk,Martin Dichgans,Johannes Kornhuber,Lutz Frölich,Isabella Heuser,Oliver Peters,Jörg B. Schulz,Sibylle G. Schwab,Wolfgang Maier +11 more
TL;DR: A SORL1 haplotype was found which was associated with CSF levels of amyloid-beta cleavage products, measured as altered levels of Abeta42, suggesting that SORl1 gene variants might influence AD pathology.
Journal ArticleDOI
Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI
Steffen Wolfsgruber,Frank Jessen,Alexander Koppara,Luca Kleineidam,Klaus Schmidtke,Lutz Frölich,Alexander Kurz,Stefanie Schulz,Harald Hampel,Isabella Heuser,Oliver Peters,Friedel M. Reischies,Holger Jahn,Christian Luckhaus,Michael Hüll,Hermann-Josef Gertz,Johannes Schröder,Johannes Pantel,Otto Rienhoff,Eckart Rüther,Fritz A. Henn,Jens Wiltfang,Wolfgang Maier,Johannes Kornhuber,Michael Wagner +24 more
TL;DR: In MCI, specific aspects of SCD severity and quality are related to CSF biomarker signature indicative of prodromal AD together with either high CSF tau or CSF phosphorylated tau 181 levels.
Journal ArticleDOI
Reduced immunoreactivity of adenylyl cyclase in dementia of the Alzheimer type.
TL;DR: Results are the first to indicate that reduced levels of brain-specific AC subtypes occur in DAT, and no significant difference in immunoreactivity of AC-V/VI subtypes distributed in various other tissues was observed.
Journal ArticleDOI
Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type
TL;DR: Descriptive trends were found at the psychopathological and dynamic functional levels, which can be interpreted as evidence of effectiveness of Ginkgo biloba special extract EGb 761 in mild to moderate dementia and of local effects in the central nervous system.
Journal ArticleDOI
Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
Mathias Thelen,Cristina Razquin,Cristina Razquin,Isabel Hernández,Ana Gorostidi,Raquel Sánchez-Valle,Sara Ortega-Cubero,Sara Ortega-Cubero,Steffen Wolfsgruber,Steffen Wolfsgruber,Dmitriy Drichel,Klaus Fliessbach,Klaus Fliessbach,Tanja Duenkel,Marinella Damian,Stefanie Heilmann,Anja Slotosch,M. Lennarz,Manuel Seijo-Martínez,Ramón Reñé,Johannes Kornhuber,Oliver Peters,Christian Luckhaus,Holger Jahn,Michael Hüll,Eckart Rüther,Jens Wiltfang,Elena Lorenzo,Elena Lorenzo,Jordi Gascon,Alberto Lleó,Alberto Lleó,Albert Lladó,Jaume Campdelacreu,Fermin Moreno,Hojjat Ahmadzadehfar,Juan Fortea,Juan Fortea,Begoña Indakoetxea,Michael T. Heneka,Michael T. Heneka,Axel Wetter,Maria A. Pastor,Mario Riverol,Tim Becker,Tim Becker,Lutz Frölich,Lluís Tárraga,Mercè Boada,Michael Wagner,Michael Wagner,Frank Jessen,Frank Jessen,Wolfgang Maier,Wolfgang Maier,Jordi Clarimón,Jordi Clarimón,Adolfo López de Munain,Agustín Ruiz,Pau Pastor,Pau Pastor,Alfredo Ramirez +61 more
TL;DR: Associations between rare TREM2 variants and specific FTD subtypes (FTD-S) are investigated to provide evidence that p.T96K is associated with FTD-D and that p-L211P may contribute to its pathogenic effect, and to suggest the p.R47H variants are associated with an FTD phenotype that is characterized by the presence of underlying AD pathology.